Table I.
Demographic and baseline clinical data of the patients.
| Baseline and clinical variables | SJS | SJS/TEN overlap | TEN | Total |
|---|---|---|---|---|
| Cases, n (%) | 24 (55.8) | 9 (20.9) | 10 (23.3) | 43 |
| Mean age (range), years | 46.5 (20–77) | 54.4 (25–85) | 52.4 (21.84) | 49.5 |
| Gender, n (%) | ||||
| Male | 13 (54.2) | 7 (77.8) | 5 (50.0) | 25 |
| Female | 11 (45.8) | 2 (22.2) | 5 (50.0) | 18 |
| Underlying disease (%) | ||||
| Diabetes | 8.3 | – | 30.0 | 11.6 |
| Hypertension | 16.7 | 33.3 | 40.0 | 25.6 |
| Gout | 12.5 | – | 30.0 | 13.9 |
| Chronic kidney disease | 12.5 | 11.1 | 20.0 | 13.9 |
| Epilepsy | 12.5 | – | – | 7.0 |
| Cerebrovascular disease | 4.2 | 11.1 | 10.0 | 7.0 |
| Cardiovascular disease | 4.2 | 22.2 | 10.0 | 9.3 |
| HIV infection | 33.3 | 22.2 | 60.0 | 37.2 |
| Tuberculosis | 4.2 | 11.1 | 20.0 | 9.3 |
| Viral hepatitis B/C | – | – | 20.0 | 4.7 |
| Other | 8.3 | – | – | 11.6 |
| Alcohol drinking | 12.5 | 22.2 | 10.0 | 14.0 |
| History of malignancy | 12.5 | – | 20.0 | 11.6 |
| History of allergy | 12.5 | 11.1 | 10.0 | 11.6 |
SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; HIV, human immunodeficiency virus.